Showing 7211-7220 of 10620 results for "".
- Dietary Choices and Their Impact on Cardiometabolic Health and Diabetes Riskshttps://reachmd.com/news/dietary-choices-and-their-impact-on-cardiometabolic-health-and-diabetes-risks/2476116/For clinicians confronting a surge in metabolic disorders, the tug-of-war between ultra-processed convenience foods and time-honored traditional diets represents a critical front in cardiometabolic care. Clinicians are witnessing how consumption of ultra-processed foods—industrial fo
- Transforming Urology: Overcoming Barriers and Exploring Innovationshttps://reachmd.com/news/transforming-urology-overcoming-barriers-and-exploring-innovations/2476104/For the urologist in a busy tertiary program, the promise of advanced surgical devices is shadowed by departmental resistance and regulatory complexities, just as novel non-surgical strategies are emerging to transform stricture care. As surgical technology continues
- Unraveling Complex Allergies: New Frontiers in Treating Eosinophilic Esophagitis and Oral Anaphylaxishttps://reachmd.com/news/unraveling-complex-allergies-new-frontiers-in-treating-eosinophilic-esophagitis-and-oral-anaphylaxis/2476105/Facing a surge in food allergies, healthcare providers find themselves grappling with treatment limitations. Improved understanding of inflammatory responses in conditions like Eosinophilic Esophagitis (EoE) and oral anaphylaxis heralds new therapeutic pathways. Buil
- Evaluating the Impact of Early Colorectal Cancer Screening in the 45-49 Age Grouphttps://reachmd.com/news/evaluating-the-impact-of-early-colorectal-cancer-screening-in-the-45-49-age-group/2476109/Colorectal cancer is the third leading cause of cancer-related deaths worldwide (WHO, 2022), and recent updates to screening guidelines have shifted the focus to younger populations. How have these changes affected diagnosis rates, especially amidst the backdrop of a global pandemic?
- Allergan Aesthetics Announces New ‘Faces of Natrelle’ Campaignhttps://reachmd.com/news/allergan-aesthetics-announces-new-faces-of-natrelle-campaign/2476065/Allergan Aesthetics, an AbbVie company, has introduced “Faces of Natrelle,” a campaign centered on patient narratives surrounding breast augmentation and reconstruction using Natrelle silicone-filled breast implants. The initiative features 9 women selected through a national casting call,
- Evolving Strategies in Osteoporosis Management: Integrating Pharmacotherapy, Exercise, and Advanced Diagnosticshttps://reachmd.com/news/evolving-strategies-in-osteoporosis-management-integrating-pharmacotherapy-exercise-and-advanced-diagnostics/2476053/Amid an aging population where osteoporosis-related fractures threaten mobility and independence, clinicians are turning to evolving management strategies, tailored exercise regimens for cancer survivors, and innovative diagnostics to safeguard skeletal health. Recen
- Chronic Plaque Psoriasis: Evolving Combination Therapies for More Effective Managementhttps://reachmd.com/news/chronic-plaque-psoriasis-evolving-combination-therapies-for-more-effective-management/2476060/Chronic plaque psoriasis is defying monotherapy, leaving patients to oscillate between inadequate clearance and burdensome side effects; the evolving landscape of combination therapies is offering a promising shift toward more effective and tolerable regimens. Buildi
- Innovative Therapy for Binge-Eating Disorder in Veteranshttps://reachmd.com/news/innovative-therapy-for-binge-eating-disorder-in-veterans/2476018/Binge-eating disorder (BED) complicates obesity management and inflicts disproportionate harm on veterans, underscoring an urgent need for targeted interventions (Smith et al., 2023). Traditional approaches have struggled to sustain both weight loss and binge suppression, leaving man
- Transforming Diabetes Care: Integrating GLP-1 Agonists with Adjunct Therapieshttps://reachmd.com/news/transforming-diabetes-care-integrating-glp-1-agonists-with-adjunct-therapies/2476019/As diabetes-related complications surge, clinicians are turning to adjunct therapies to rescue patients from the limits of standard insulin regimens; integrating GLP-1 receptor agonists markedly enhances glycemic control, reduces insulin requirements, and supports weight management as demon
- Integrating Social Determinants and Therapeutic Innovations in Diabetes Managementhttps://reachmd.com/news/integrating-social-determinants-and-therapeutic-innovations-in-diabetes-management/2476032/Diabetes management is as much about understanding social contexts as it is about leveraging the latest medical advancements. Unpacking these layers is critical in shaping effective and equitable healthcare strategies. Social determinants like neighborhood deprivation exert a measura